Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
-
Tracks: Adult ID
Presentations:
The diagnostic efficacy for combination of nurse-assesed food consumptions and shaking chills in predicting bacteremia at the time of blood culture
Takayuki Komatsu, MD, PhD
;
Erika Takahashi, MD
;
Kentaro Mishima, MD
;
Takeo Toyoda, MD, PhD
;
Fumihiro Saitoh, MD
;
Manabu Sugita, MD, PhD
;
Joel Branch, MD
;
Kenji Inoue, MD, PhD
Location of Acquisition Impacts the Discharge Status and Length of Stay of Patients with Gram-Positive Bloodstream Infections in Community Hospitals
Julia Messina, MD, MSc
;
Rebekah W. Moehring, MD, MPH
;
Vance G. Fowler Jr., MD
;
Daniel J. Sexton, MD, FIDSA, FSHEA
;
Deverick Anderson, MD, MPH, FIDSA, FSHEA
Initial Empiric Carbapenem Use Does Not Improve Mortality in Critically Ill patients with Gram-Negative Bacteremia BUT Increases Multi-Drug Resistant Organisms
Rui Min Foo, MBBS, MRCP (UK)
;
Anupama Vasudevan, BDS, MPH
;
Isaac Taoyang Low, BSS
;
Amartya Mukhopadhyay, MBBS, MD, MRCP, FRCP, EDIC
;
Paul Tambyah, MBBS, M.D., FSHEA
Prediction of Fluoroquinolone Resistance in Patients with Gram-Negative Bloodstream Infection
Ansal Shah, MD
;
Seejil Dan, MD
;
Julie Ann Justo, Pharm D, MS
;
P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP
;
Joseph Kohn, PharmD, BCPS
;
Helmut Albrecht, MD
;
Majdi Al-Hasan, MD
Association between Inappropriate Empirical Antimicrobial Therapy and Hospital Length of Stay in Gram-Negative Bloodstream Infections
Sarah Cain, BS
;
Joseph Kohn, PharmD, BCPS
;
P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP
;
Julie Ann Justo, Pharm D, MS
;
Helmut Albrecht, MD
;
Majdi Al-Hasan, MD
Evaluation of Empiric Therapy with Third-Generation Cephalosporins for Bloodstream Infections Secondary to Chromosomally-Mediated AmpC-Producing Enterobacteriaceae
Caroline Derrick, PharmD, BCPS
;
Zhiqiang K. Lu, PhD
;
P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP
;
Majdi Al-Hasan, MD
;
Christopher M. Bland, PharmD, BCPS
;
Bruce Jones, PharmD, BCPS
;
Kayla R. Stover, PharmD, BCPS
;
S. Travis King, PharmD, BCPS
;
Virginia Fleming, PharmD, BCPS
;
Trisha N. Branan, PharmD, BCPS
;
David Cluck, PharmD
;
Brian Odle, PharmD
;
V. Paul Dimondi, PharmD, BCPS
;
Sandy Estrada, Pharm.D., BCPS (AQ-ID)
;
Julie Ann Justo, PharmD, MS, BCPS, AAHIVP
Clinical features and risk factors for development of breakthrough Gram-negative bacteremia during carbapenem therapy
Ji-Yong Lee, internal medicine/MD
;
Cheol-in Kang, MD
;
Jae-Hoon Ko, MD
;
Ji-Yeon Lee, MD
;
Hye-Ri Seok, MD
;
Ga-Eun Park, MD
;
Sun Young Cho, MD
;
Young Eun Ha, MD
;
Doo Ryun Chung, MD PhD
;
Kyong Ran Peck, MD
;
Jae-Hoon Song, PhD, MD
;
Woo Joo Lee, MD
Profile of enterococcal bloodstream infection at a tertiary-care hospital in Japan over a 10-year period: Characteristics, outcomes, and predictors for 30-day mortality
Hiroyuki Suzuki, MD
;
Naoto Hosokawa, MD, PhD
;
Yoshihito Otsuka, PhD
;
Ryota Hase, MD
;
Daisuke Suzuki, MD
;
Kazuyasu Miyoshi, MD
;
Shunsuke Uno, MD
;
Akihiro Amma, MD
;
Akihiko Shimizu, MD
Risk Factors Associated with the Development of Linezolid Non-susceptible Vancomycin-Resistant Enterococcus faecium
Tiffeny Smith, PharmD
;
Pranita D. Tamma, MD, MHS
;
Kathryn Dzintars, PharmD
;
Edina Avdic, MBA, PharmD, BCPS AQ-ID
;
Sara Cosgrove, MD, MS, FIDSA, FSHEA
Risk Factors for Treatment Failure and Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
Rana F. Hamdy, MD, MPH
;
Alice J Hsu, PharmD
;
Chris R. Stockmann, MSc
;
Jared a. Olson, PharmD
;
Matthew Bryan, PhD
;
Adam L. Hersh, MD, PhD
;
Pranita D. Tamma, MD, MHS
;
Jeffrey S. Gerber, MD, PhD
Telavancin in the Treatment of Staphylococcus aureus Bacteremia
Louis Saravolatz, MD, FIDSA
;
Kerry Cleveland, MD, FACP, FIDSA, FSHEA
;
Khalid Rikabi, MD
;
Ali Hassoun, MD FIDSA FACP
;
Leonard B Johnson, MD, FIDSA
;
Cedric W. Spak, MD
;
Sharon Valenti, CNP
;
Susan Szpunar, PhD
Comparative Effectiveness of Third Generation Cephalosporins versus Penicillinase-Stable Penicillins for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study
Jennifer Mcdanel, PhD
;
Mary-Claire Roghmann, MD, MS, FIDSA, FSHEA
;
Eli Perencevich, MD, MS, FIDSA, FSHEA
;
Michael Ohl, MD, MSPH
;
Michihiko Goto, MD, MSCI
;
Daniel Livorsi, MD
;
Makoto Jones, MD, MS
;
Justin Albertson, MS
;
Rajeshwari Nair, MBBS, MPH
;
Amy O'shea, PhD
;
Marin Schweizer, PhD
Impact of routine bedside infectious diseases consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults
Rebecca Saunderson, BMedSci MBBS MPhil
;
Theodore Gouliouris, BM BCh
;
Emma Nickerson, MBBS PhD
;
Edward Cartwright, MBBS PhD
;
Angela Kidney, BSc
;
Sani Aliyu, MBBS FRCP FRCPath
;
Nicholas Brown, MBBS FRCPath
;
Direk Limmathurotsakul, MD PhD
;
Sharon Peacock, PhD FRCP FRCPath
;
Estee Torok, PhD FRCP FRCPath
Mortality outcomes of cefazolin versus nafcillin for methicillin-sensitive S.aureus blood stream infection: a 4-year prospective cohort study in a Californian tertiary medical center
Simon Pollett, MBBS, BMedSci, DTMH, FRACP
;
Sanjiv Baxi, MS, MD, MPH
;
Peter Bacchetti, PhD
;
Henry Chambers, MD, FIDSA
¨Staphylococccus aureus Bloodstream Infections in Latin America: Results of a Large Multinational Cohort Study¨
Carlos Seas, MD, FIDSA
;
Coralith Garcia, MD
;
Mauro Costa Salles, MD
;
Jaime Labarca, MD
;
Carlos Alvarez, MD, FIDSA
;
Carlos Luna, MD
;
Carlos Mejia, MD
;
Jeannnete Zurita, MD
;
Manuel Guzman-Blanco, MD
;
Eduardo Rodriguez-Noriega, MD
;
Jinnethe Reyes, PhD
;
Cesar Arias, MD, PhD, FIDSA
;
Cesar Carcamo, MD, PhD
;
Eduardo Gotuzzo, MD, FIDSA
Adherence to quality care indicators targeting Staphylococcus aureus bloodstream infections resulted in a better outcome
Miki Nagao, M.D., Ph.D.
;
Masaki Yamamoto, M.D., Ph.D
;
Yasufumi Matsumura, M.D., Ph.D.
;
Taro Noguchi, M.D.
;
Satoshi Nakano, M.D.
;
Karin Kato, M.D.
;
Tomoyuki Yunoki, M.D.
;
Shunji Takakura, M.D., Ph.D.
;
Satoshi Ichiyama, M.D., Ph.D.
Achromobacter xylosoxidans Bacteremia in Patients with Cancer
Flor Sánchez-Vargas, MD
;
Minh Ho, DO
;
Joseph Paruolo, MD
;
Kelly Kynaston, DO
;
Tyler Stutzman, MPH
;
Ana Velez, M.D., F.A.C.P.
;
John Greene, MD, FACP, FSHEA
Five-Year Mortality of Native Versus Prosthetic Valve Endocarditis in a Population-Based Cohort
Abdelghani El Rafei, MD
;
Daniel C. Desimone, MD
;
James M. Steckelberg, MD, FIDSA
;
Muhammad R. Sohail, MD, FIDSA
;
Walter R. Wilson, MD, FIDSA
;
Larry M. Baddour, MD, FIDSA
Endocarditis Caused by MRSA with Reduced Susceptibility to Vancomycin and Daptomycin and Resistance to Ceftaroline: Treatment Approach and Evidence of Patient to Patient Transmission
Masayuki Nigo, MD
;
L. Paola Carvajal, BSc
;
Truc Tran, PhamD
;
Rafael Rios, MSc
;
Jose Munita, MD
;
Diana Panesso, PhD
;
Audrey Wanger, PhD
;
Lorena Diaz, PhD
;
Cesar Arias, MD, PhD, FIDSA
Beta Hemolytic Streptococcus Infective Endocarditis: Factors Associated with Early Mortality
Abdelghani El Rafei, MD
;
Daniel Desimone, MD
;
Christopher Desimone, MD, PHD
;
Brian Lahr, MS
;
James Steckelberg, MD, FIDSA
;
Muhammad R. Sohail, MD, FIDSA
;
Walter R. Wilson, MD, FIDSA
;
Larry Baddour, MD, FIDSA
Aminoglycosides for Surgically Treated Enterococcal Endocarditis
Jona Banzon, MD
;
Syed Hussain, MD
;
Steven Gordon, MD, FIDSA, FSHEA
;
Gosta Pettersson, MD, PhD
;
Robert Butler, MS
;
Nabin Shrestha, MD, MPH, FIDSA, FSHEA
CME Credits:
ACPE Credits:
ACPE Number:
